Prof Francesco Cosentino speaks to ecancer at the International Aspirin Foundation Scientific Conference 2019 in Rome about the guidelines surrounding the use of aspirin in patients with diabetes.

He discusses which patients might benefit from using aspirin, but points out that the guidelines governing this are controversial.

Prof Cosentino mentions the ASCEND trial, which aims to investigate the use of aspirin as a preventative measure in diabetic patients.

Read more on the highlights from the 2019 International Aspirin Foundation Scientific Conference here.